Navigation Links
Health Targets To Treat Cancer Patients Unlikely To Be Met

A Scottish Executive target to treat all cancer patients within two months is unlikely to be met by NHS Scotland. Health Minister Andy Kerr has ordered// the appointment of "service improvement managers" to try to tackle the problem.

The Executive had aimed to ensure that all cancer patients started treatment within two months of an urgent referral from their GP. New health service figures reveal that a quarter of cancer patients were not referred within that time between October and December 2005. Delays have also worsened for some types of cancer, including bowel, skin and stomach cancers.

The target specified that from the beginning of 2006, the maximum waiting time between urgent referral and treatment should be two months. However the latest statistics have shown that across Scotland, only 74% of cases met that deadline, compared with 75% during the previous three months. And in certain types of cancer less than 70% of the cases met the target. The latest figures for the first quarter of 2006, the initial period for which the targets apply seem most likely to fall short of the objectives.

Mr Kerr while admitting that the latest figures were "not good enough", he said that he personally felt frustrated and he said that he knows how distressing it would be for people to have to wait longer for the required treatment.

Shona Robison, the SNP's health spokeswoman, said cancer patients were being let down by the Scottish Executive. While stating that it was right on the minister to have apologised, she said that that the most important thing for him, to do was to try and fix the problem.

Meanwhile the cancer charities have expressed concern at the lack of progress on reducing waits. Anna Wood, campaigns and policy manager at Breast Cancer Care, said: "It is unacceptable for any cancer patient to be forced to endure treatment delays." Jenny Whelan, the head of Cancer backup Scotland, said: that they receive m any calls to their help line from anxious patients concerned about delays with their treatment, at a time when they should be focusing on trying to recover.


'"/>




Related medicine news :

1. Startling Expose – Physicians Often Have No Regular Source Of Health Car
2. Want a Healthy brew? Have some Tea!
3. Healthcare sector is now a multi billion-dollar industry in India
4. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
5. Health at heights
6. Health Officials Recommend Flu Vaccine
7. Slightly High BP Poses Health Risk
8. Unsatisfactory Grade On Womens Health Issues
9. Iodex goes to SmithKline Beecham consumer Healthcare
10. Healthy Medicine Or Harmful Intoxicant?
11. Healthy snacks improve nutrition of kids
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: